Description
Product Name: Ceflax-TZ 1125 Injection
Generic Name: Ceftriaxone & Tazobactam for Injection
Product Overview
Ceflax-TZ 1125 Injection is a broad-spectrum antibacterial formulation designed to effectively treat a wide range of bacterial infections. It combines Ceftriaxone, a third-generation cephalosporin antibiotic, with Tazobactam, a beta-lactamase inhibitor that enhances the antibiotic’s effectiveness by preventing bacterial resistance mechanisms.
This combination works by stopping bacterial cell wall formation and protecting the antibiotic from degradation by beta-lactamase enzymes produced by resistant bacteria. Ceflax-TZ 1125 is commonly used in hospitals and clinical settings for the treatment of moderate to severe infections.
Key Benefits
-
Broad-spectrum antibacterial activity
-
Effective against beta-lactamase producing bacteria
-
Helps combat resistant bacterial infections
-
Suitable for treating serious bacterial infections
-
Reliable antibiotic therapy for hospital use
Composition
Each vial contains:
-
Ceftriaxone: 1000 mg
-
Tazobactam: 125 mg
Total Strength: 1125 mg
Dosage Form
Sterile Powder for Injection
Indications
-
Respiratory tract infections
-
Urinary tract infections (UTIs)
-
Skin and soft tissue infections
-
Intra-abdominal infections
-
Bone and joint infections
-
Gynecological infections
-
Septicemia and other bacterial infections
Dosage & Administration
Ceflax-TZ 1125 Injection should be administered intravenously (IV) or intramuscularly (IM) under the supervision of a qualified healthcare professional. The dosage depends on the severity of infection and the patient’s medical condition.
Storage Instructions
-
Store in a cool and dry place
-
Protect from direct sunlight
-
Keep out of reach of children
Safety Information
-
For use under medical supervision only
-
Do not exceed the recommended dosage
-
Inform your doctor about any allergies or ongoing medical conditions before use
Manufacturing License No.: N-MB/16/185
Why Choose Ceflax-TZ 1125?
Ceflax-TZ 1125 Injection offers an effective combination of Ceftriaxone and Tazobactam, providing enhanced antibacterial coverage and improved effectiveness against resistant bacterial infections.
